(Image: Getty/Murat Göçmen)

State of the Industry: What readers have to say

By Melissa Fassbender

Outsourcing-Pharma recently conducted a second ‘state of the industry’ survey to gauge views about the current state of the global pharmaceutical outsourcing market and the evolving relationships of those involved.

Top 7 CROs soon to exceed 50% market share

Top 7 CROs soon to exceed 50% market share, Parexel CFO says

By Zachary Brennan

As PRA Health Services goes public this week, nearly all of the top CROs are now public and the top tier of these companies could control about half of the outsourcing industry, Parexel CFO Ingo Bank said Tuesday.

“Many small biopharmaceutical companies have successfully raised capital and are now deploying those funds,

Biotech cash to be a boon for CROs, Parexel says

By Zachary Brennan

As small and medium sized biopharma companies continue to raise cash through IPOs and elsewhere, CROs will see an uptick in outsourced work, Parexel founder, chairman and CEO Joseph von Rickenbach predicted in the company’s earnings call last week.


Follow us

Featured Events

View more


View more


Featured Suppliers

All suppliers